• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fecal microbiota transplant in liver diseases: Current evidence and future directions.

作者信息

Karna Rahul, Babich Michael

机构信息

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Minnesota, Minneapolis, Minnesota, USA.

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.

出版信息

Clin Liver Dis (Hoboken). 2024 Jun 5;23(1):e0154. doi: 10.1097/CLD.0000000000000154. eCollection 2024 Jan-Jun.

DOI:10.1097/CLD.0000000000000154
PMID:38841199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11152867/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046c/11152867/651131bf6021/xcl-23-e0154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046c/11152867/651131bf6021/xcl-23-e0154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046c/11152867/651131bf6021/xcl-23-e0154-g001.jpg

相似文献

1
Fecal microbiota transplant in liver diseases: Current evidence and future directions.粪便微生物群移植在肝脏疾病中的应用：当前证据与未来方向
Clin Liver Dis (Hoboken). 2024 Jun 5;23(1):e0154. doi: 10.1097/CLD.0000000000000154. eCollection 2024 Jan-Jun.
2
Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy.失代偿期肝硬化患者的粪便微生物群移植：安全性和有效性的系统评价
Antibiotics (Basel). 2022 Jun 23;11(7):838. doi: 10.3390/antibiotics11070838.
3
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.AGA 临床实践指南：基于粪便微生物群的疗法治疗特定胃肠道疾病。
Gastroenterology. 2024 Mar;166(3):409-434. doi: 10.1053/j.gastro.2024.01.008.
4
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions.粪便微生物群移植在肝性脑病管理中的作用：当前趋势与未来方向
World J Hepatol. 2024 Jan 27;16(1):17-32. doi: 10.4254/wjh.v16.i1.17.
5
Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Infection in Rural Hospitals?粪便微生物移植在农村医院治疗复发性感染中的作用？
Front Public Health. 2021 Jun 9;9:670941. doi: 10.3389/fpubh.2021.670941. eCollection 2021.
6
Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.粪便微生物移植，在胃肠道疾病中除艰难梭菌之外的用途。
Gastroenterol Hepatol. 2022 Mar;45(3):223-230. doi: 10.1016/j.gastrohep.2021.05.009. Epub 2021 Jun 9.
7
Clostridium difficile Infection and Fecal Microbiota Transplant.艰难梭菌感染与粪便微生物群移植
AACN Adv Crit Care. 2016 Jul;27(3):324-337. doi: 10.4037/aacnacc2016703.
8
Research Progress of Fecal Microbiota Transplantation in Liver Diseases.粪便微生物群移植在肝脏疾病中的研究进展
J Clin Med. 2023 Feb 20;12(4):1683. doi: 10.3390/jcm12041683.
9
Fecal Microbiota Transplantation in Liver Cirrhosis.粪便微生物群移植治疗肝硬化
Biomedicines. 2023 Oct 30;11(11):2930. doi: 10.3390/biomedicines11112930.
10
Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders.肠道微生态移植治疗胃肠道及肠外疾病
Future Microbiol. 2020 Aug;15:1173-1183. doi: 10.2217/fmb-2020-0061.

引用本文的文献

1
Acute-on-Chronic Liver Failure: Steps Towards Consensus.急性-on-慢性肝衰竭：迈向共识的步骤。 （注：这里“Acute-on-Chronic”直接这样翻译不太准确，推测可能是“急性慢性叠加”之类的意思，但按要求直接翻译了。）
Diagnostics (Basel). 2025 Mar 17;15(6):751. doi: 10.3390/diagnostics15060751.
2
Nonobstructive Recurrent Cholangitis After Hepatobiliary Tract Diversion in Patients With Surgically Altered Anatomy: A Challenging Problem.解剖结构改变患者行肝胆管改道术后的非梗阻性复发性胆管炎：一个具有挑战性的问题
ACG Case Rep J. 2025 Mar 5;12(3):e01639. doi: 10.14309/crj.0000000000001639. eCollection 2025 Mar.

本文引用的文献

1
Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases.噬菌体疗法：靶向肠道细菌微生物群治疗肝脏疾病。
JHEP Rep. 2023 Sep 23;5(12):100909. doi: 10.1016/j.jhepr.2023.100909. eCollection 2023 Dec.
2
Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial.严重酒精性肝炎患者粪便微生物群移植与泼尼松龙的比较：一项随机试验
Hepatol Int. 2023 Feb;17(1):249-261. doi: 10.1007/s12072-022-10438-0. Epub 2022 Dec 5.
3
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
粪便微生物移植治疗非酒精性脂肪性肝病的随机临床试验。
Front Cell Infect Microbiol. 2022 Jul 4;12:759306. doi: 10.3389/fcimb.2022.759306. eCollection 2022.
4
Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient.粪便微生物移植可改善肝性脑病的认知功能，其效果因供体和受体而异。
Hepatol Commun. 2022 Aug;6(8):2079-2089. doi: 10.1002/hep4.1950. Epub 2022 Apr 5.
5
Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial.粪便微生物群移植治疗酒精相关性慢加急性肝衰竭：一项开放标签临床试验。
Hepatol Int. 2022 Apr;16(2):433-446. doi: 10.1007/s12072-022-10312-z. Epub 2022 Mar 28.
6
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis.供体粪便微生物群移植改变了患有脂肪性肝炎的肥胖个体的肠道微生物群和代谢物。
Hepatol Commun. 2020 Oct 7;4(11):1578-1590. doi: 10.1002/hep4.1601. eCollection 2020 Nov.
7
Human gut microbiota/microbiome in health and diseases: a review.人类肠道微生物组/微生物群在健康和疾病中的作用：综述。
Antonie Van Leeuwenhoek. 2020 Dec;113(12):2019-2040. doi: 10.1007/s10482-020-01474-7. Epub 2020 Nov 2.
8
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.异体粪菌移植治疗非酒精性脂肪性肝病患者改善异常小肠通透性：一项随机对照试验。
Am J Gastroenterol. 2020 Jul;115(7):1055-1065. doi: 10.14309/ajg.0000000000000661.
9
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients.细菌抗原易位和年龄作为非酒精性脂肪性肝病患者全身炎症中与体重指数无关的促成因素。
Liver Int. 2020 Sep;40(9):2182-2193. doi: 10.1111/liv.14571. Epub 2020 Jul 1.
10
Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study.粪便微生物群移植治疗乙型肝炎 e 抗原阳性慢性乙型肝炎患者：一项初步研究。
Dig Dis Sci. 2021 Mar;66(3):873-880. doi: 10.1007/s10620-020-06246-x. Epub 2020 Apr 11.